Abstract
The chitinase Cht3 plays a major role in the chitinolytic activity of the pathogenic yeast Candida albicans and has also been proposed as a major antigen with potential for vaccine development against systemic candidiasis. The current study aims to enhance our knowledge on the role of Cht3 in cell surface organization and virulence of C. albicans. To this end, CHT3 deletion mutants generated in two wild-type genetic backgrounds (reference strain SC5314 and clinical isolate 124A) were phenotypically characterized. Absence of CHT3 did not affect growth rate but affected cell separation of dividing yeast cells at 37 °C. Further, cht3Δ mutants showed enhanced levels of surface-exposed chitin and slightly increased resistance to the cell wall perturbants Calcofluor white and Congo red and the β-1,3-glucan hydrolyzing enzyme Zymolyase, while the total level of chitin appeared unaltered. Deletion of one gene copy diminished CHT3 transcript levels by about 90% in both backgrounds. In strain 124A, showing two-fold higher CHT3 expression than SC5314, loss of CHT3 was compensated by upregulation of CHT2. Infection studies with cht3Δ mutants in strain 124A showed that CHT3 deletion led to attenuated virulence. Histological analysis of infected kidneys showed that CHT3 deletion did not affect the morphology of C. albicans cells during infection, but it appeared to delay activation of macrophages for efficient yeast killing. In conclusion, this study demonstrated that Cht3 activity is required for normal cell separation during yeast growth, cell surface organization, and full virulence of C. albicans in vivo. Its importance for virulence aligns with the earlier observed potential of Cht3 as vaccine candidate and warrants further studies to elucidate the mechanisms underlying its role in virulence and interaction with the host immune system.
1 Introduction
The Candida albicans genome harbors four distinct chitinase encoding genes: CHT1 - 4. Cht1, 2, and 3 are homologous to Saccharomyces cerevisiae Cts1 (; ), whereas Cht4 has closer homology to S. cerevisiae Cts2. Analysis of CHT1, 2 and 3 deletion mutants in auxotrophic parental backgrounds indicated that, similar to ScCts1, Cht3 is essential for proper cell separation during growth and division of C. albicans yeast cells (; ). In contrast, deletion of CHT1 and CHT2 was observed to have only limited effects under the tested conditions and did not affect cell separation (; ). Studies on CHT4 deletion mutants have not been reported yet but its heterologous expression was shown to complement sporulation defects of cht2 mutants in Ashbya gossypii ().
Given its involvement in cell division, CHT3 displays higher expression levels in cultures containing unicellular yeasts compared to those with hyphal growth. The same was observed for CHT2 while expression of CHT1 could not be detected in either condition (). Supporting the notion that Cht3 is the predominant chitinase in C. albicans, deletion of CHT3 led to drastically decreased chitinase activity in both cell-associated as well as culture supernatant fractions. CHT1 deletion did not result in diminished chitinase activity, while for cht2Δ mutants this was inconclusive as only a slight decrease in yeast cell-associated activity was reported in one of the papers (; ). Cht2 has been found to be covalently attached to the cell wall (; ) and specifies a predicted C-terminal glycosylphosphatidylinositol (GPI) anchoring peptide (). Cht1, 3 and 4 lack GPI anchoring sequences and are therefore likely to be secreted, consistent with the diminished chitinase activity in the growth medium of cht3Δ mutants ().
Expression of CHT3 peaks during the M/G1 phase of the cell cycle (). This temporal peak in expression is linked to the role of Cht3 in cell division, where it participates in the cleavage of chitin at the septum formed during this process. Thus, deletion of CHT3 leads to defects in cell separation, resulting in the formation of cell chains or agglomerates with chitin accumulation at the budding site, while hyphal growth remains unaffected by the Cht3 knockout (; ). The CHT3 expression peak during the M/G1 phase coincides with the activation of other genes implicated in cell separation such as ENG1, SCW11, and DSE1, which encode an endo-β-1,3-glucanase, a β-1,3-glucan-modifying enzyme, and a daughter cell-specific protein of unknown function, respectively, all controlled by the transcriptional regulator Ace2 (). Also in line with their implication in cell separation, proteomic studies showed elevated levels of Cht3, Eng1, and Scw11 in the culture solution of unicellular budding yeasts compared to hyphal cells (; ).
In our previous studies, Cht3 emerged as an antigen of interest when a dithiothreitol (DTT) extract from intact cells encapsulated in dioctadecyldimethylammonium bromide:monoolein (DODAB: MO) liposomes was utilized for immunizing mice (, ). In further studies, immunization with recombinant Cht3 combined with secreted aspartyl proteinase 2 (Sap2), encapsulated in the same liposomes, led to a significant protection of mice against lethal systemic candidiasis and stimulated high antibody production (). Interestingly, a formulation containing only the recombinant Cht3 in the liposomes induced the production of anti-Cht3 antibodies capable of opsonizing yeast cells at the mother-daughter scars. These findings confirmed the active presence of Cht3 at these sites in the cell wall, consistent with its implication in cell separation ().
We aim to deepen our understanding of the role of Cht3 in C. albicans cell wall organization and virulence and correlating it with the protective effects observed previously. The recombinant protein, purified and applied as a vaccine candidate in our previous studies, originated from reference strain SC5314 and, notably, demonstrated protective activity against a clinical isolate (strain 124A). The cht mutants generated in earlier studies utilized auxotrophic selection markers to delete chitinase genes in a parental strain with deletions in URA3, HIS1, and ARG4 or applied the Ura-blaster system (; ). These techniques have limitations, as the imposed genetic alterations and procedures can interfere with proper marker gene expression, potentially affecting cellular physiology, which might result in misleading outcomes of virulence studies (). Therefore, in this study, we generated and phenotypically characterized cht3Δ deletion mutants in wild-type (WT) backgrounds, clinical isolate 124A and reference strain SC5314, utilizing the SAT1 flipper system ().
2 Materials and methods
2.1 Strains and growth conditions
Strains used in this study are listed in Supplementary Table S1. Unless stated otherwise, yeast strains were routinely (pre-)cultured in YPD medium (1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glucose), supplemented with 2% (w/v) agar for solid media when required, and incubated at 37°C.
2.2 CHT3 gene deletion
CHT3 (GenBank Number: XM_714255.1) deletion was carried out using the SAT1 flipper system () combined with CRISPR RNA-Cas9 ribonucleoprotein complexes (RNPs) () to increase the efficiency of integration into the correct locus, following procedures described previously (). In brief, CHT3 flanking regions of about 500 bp were amplified (see Supplementary Table S2 for primer sequences) and cloned into plasmid pSFS2. The sequence-verified deletion cassette was mixed with a CRISPR guide (Supplementary Table S2) and Cas9 protein (IDT, Leuven) and transformed into C. albicans cells by electroporation (). Deletion mutants were selected following protocols described by Reuß et al (). Finally, PCR validation of mutants and excision of the cassette was performed as shown in Supplementary Figure S1.
2.3 Growth kinetics
To assess growth kinetics, precultured cells of cht3Δ mutants and the corresponding parental strains were diluted to an initial OD600 of 0.1 in fresh YPD medium and incubated in 96-well plates at 30°C and 37°C. The increase in OD600 was recorded hourly following a five-seconds agitation step using a SpectraMax 340 microplate reader (Molecular Devices). Data represent the mean of three independent biological replicates measured in triplicate.
2.4 Cell separation assays
Effects of deleting the CHT3 gene on cell separation were assessed by flow cytometry (FC) with cultures grown at 37°C to logarithmic (OD600 = 1 - 2) or stationary phase. Harvested cells were fixed with 4% paraformaldehyde for 30 min, washed with PBS, and analyzed on a MACSQuant® Analyzer 10 (Miltenyi Biotec). For each sample, 20,000 events were recorded of which single-cell events were identified through a two-step gating strategy (FSC-A vs. FSC-W followed by SSC-A vs. SSC-W). Gates were defined independently for each genetic background as the two WT parental strains showed slightly different morphological behavior in this experimental procedure. Data were analyzed using FlowJo™ v10.10.0 software (BD Life Sciences). The proportion of single-cell events was calculated relative to the total cellular population, with reductions being interpreted as impaired cell separation. Representative images of the same cell cultures were acquired using a Leica DM1000 brightfield microscope equipped with an MC170 HD digital camera to validate the FC data.
2.5 Sedimentation
Stationary phase cultures grown at 37 °C were transferred to 15 cm long glass tubes and allowed to sediment at room temperature (RT). Sedimentation was monitored over time by measuring the OD600 of 20 μL samples collected 2 cm below the liquid surface.
2.6 Biofilm formation
Biofilm formation assays were performed in YPD and Roswell Park Memorial Institute (RPMI)-1640 medium buffered to pH 7.0 with 0.165 M morpholinopropanesulfonic acid (MOPS). Cells from overnight precultures were diluted to an OD600 of 0.5 in fresh YPD or RPMI - 1640 and incubated in 96-well plates for 24 h at 37°C without shaking. Biofilm mass was quantified using the Crystal violet (CV) assay (), while metabolic activity was assessed via the XTT assay () as previously described. Data shown are the mean of four independent biological replicates per strain, each measured with six technical replicates.
2.7 Biochemical determination of the chitin and protein cell wall content
Cell wall isolation from cells grown to logarithmic phase at 37°C was performed as previously described (). Chitin and protein content in the samples were determined using colorimetric assays according to () and values were expressed as a percentage of dry cell wall weight.
2.8 Quantitative flow cytometry analysis of chitin and confocal microscopy
Yeast cultures were prepared for FC analysis as described above. Chitin in fixed cells (2 × 107) was stained with wheat germ agglutinin conjugated to fluorescein isothiocyanate (WGA-FITC; 100 μg/mL, Sigma-Aldrich) for 1 h, or for 5 min with Calcofluor white (CFW, 25 μg/mL, Glentham Life Science), both at 37°C. Following staining, cells were washed three times with PBS and fluorescence intensity was measured by FC, acquiring 50,000 events per sample. For each strain, an autofluorescence threshold was established based on the median fluorescence intensity (MFI) of the corresponding unstained control population.
Confocal microscopy was performed using the same fluorescent dyes. For dual labeling of chitin and mannan, cells were first incubated for 15 min with WGA-FITC, after which Concanavalin A conjugated to tetramethylrhodamine (ConA-Rho; 100 μg/mL, Molecular Probes) was added and incubation was continued for another 45 min. Cells were washed with PBS and mounted for imaging. Confocal acquisition was performed using a Zeiss LSM 710 Laser Scanning Microscope equipped with a Plan-Apochromat 63×/1.40 oil immersion objective (DIC M27). Images were acquired at 8-bit depth and 1024 × 1024 resolution and processed using ZEN software (version 3.8.99.00000).
2.9 Response to cell surface-perturbing agents
Sensitivity to cell surface-perturbing agents was assessed by spotting 4 µL of yeast precultures diluted to an OD600 of 1.0 and four serial ten-fold dilutions thereof onto YPD agar supplemented with Congo red (CR), CFW, caffeine (10 mM), caspofungin (90 ng/mL) or SDS (0.035% (w/v)). CR and CFW concentrations were adjusted according to the sensitivity of the parental strain background: 100 μg/mL CFW and 75 μg/mL CR for SC5314, and 25 μg/mL of each compound for strain 124A. Plates were incubated at 37°C and growth was documented by photography after 24 and 48 h. At least two individual experiments were performed to confirm the observed phenotypes, each including two biological replicates.
CFW susceptibility was also quantified using broth microdilution assays in 96-well plates, adapted from EUCAST guidelines (; ). Briefly, cell suspensions adjusted to an OD600 of 0.01 were mixed 1:1 with CFW serial dilutions in YPD and incubated at 37°C for 24 h with continuous shaking. The minimal inhibitory concentration (MIC50) values were determined based on optical density measurements.
2.10 Zymolyase sensitivity
Logarithmic phase cells were collected, washed and adjusted to an OD600 of 2.0 in 10 mM Tris-HCl buffer (pH 7.4) containing 0.25% β-mercaptoethanol, followed by a 1 h incubation at RT. Cell suspensions and Zymolyase-20T (Amsbio) were combined in 96-well plates to achieve a final enzyme concentration of 1 U/mL. Lysis was monitored at 37°C, with OD600 readings taken at 1-min intervals following brief agitation. Curves represent the mean of three independent experiments, each including two biological replicates analyzed in triplicate.
2.11 Quantitative real-time PCR analysis of CHT gene expression
Parental strains SC5314 and 124A, along with their respective cht3Δ mutants, were cultured to exponential or stationary phase at 37°C. Total RNA was extracted following mechanical lysis with a Fastprep-24 instrument (MP Biomedicals) using TRIzol reagent (Thermo Fisher Scientific) and standard protocols. One microgram of RNA was reverse-transcribed into cDNA with the High-Capacity RNA-to-cDNA kit (Applied Biosystems). qPCR was carried out with a 7500 Fast Real-Time PCR system (Applied Biosystems) using 4 μL of 20-fold diluted cDNA and Fast SYBR Green qPCR Master Mix (Thermo Fisher Scientific) in a 10 μL reaction volume. Primer sequences are listed in Supplementary Table S2. Primer specificity and amplification efficiency for all targets, including the reference genes ACT1 and RIP1, were validated by standard curve analysis and by agarose gel electrophoresis. Ct values were corrected to ACT1 expression and normalized against RIP1 expression levels.
2.12 In vivo virulence in the mouse model of disseminated candidiasis
2.12.1 Mouse husbandry
Female BALB/c mice, eight to ten weeks old, were purchased from Charles River (Barcelona, Spain) and kept under specific pathogen-free conditions at the Institute for Research and Innovation in Health (i3S) (Porto, Portugal). All procedures involving mice were performed according to the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS 123), the 2010/63/EU directive, and Portuguese rules (DL 113/2013). Procedures were approved by the i3S institutional board responsible for animal welfare (ORBEA) and authorization to perform the experiments was issued by the competent national authority (Direção Geral de Alimentação e Veterinária) with the reference number 014036/2019-07-24.i3S.
2.12.2 Infection procedures and kidney collection
Mice were infected with WT (n = 6), heterozygous, and homozygous mutants (n = 8 each) in the 124A background. Yeast precultures were grown on Winge agar (0.3% (w/v) yeast extract, 0.2% (w/v) glucose, 2% (w/v) agar) at 30 °C for 24 h. Colonies were restreaked onto fresh Winge plates and incubated for an additional 14 h. Cells were then collected, washed, and resuspended in PBS to a final concentration of 1 × 106 cells/mL, and 100 µL were injected intravenously in the lateral tail vein. This experiment was independently repeated twice using the same number of animals per group, as described above. Progression of hematogenously disseminated candidiasis was evaluated in accordance with international guidelines, by monitoring survival, clinical behavior, appearance, body weight, temperature, hydration status, and respiratory patterns. These parameters were used to calculate animal welfare scores. Mice were euthanized by cervical dislocation upon reaching humane endpoints or at the conclusion of the experimental period.
Kidneys from euthanized mice were collected and fixed in 3.7% buffered formalin for histological analysis. Paraffin-embedded sections were stained with periodic acid–Schiff (PAS) reagent and counterstained with hematoxylin–eosin (HE) to visualize fungal morphology. Imaging was performed using a Leica DM500 microscope equipped with a Leica ICC50 W camera and LAS V4.12 software (Leica Microsystems).
2.13 In vivo virulence in Galleria mellonella
In addition to the murine model, virulence was also assessed using the invertebrate G. mellonella infection model with WT and mutants in both genetic backgrounds, following a previously described protocol ().
2.14 Macrophage killing assay
The murine macrophage cell line J774A.1 was maintained in high-glucose (4.5 g/L) Dulbecco’s Modified Eagle Medium (DMEM; Gibco), supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco), 2 mM L-glutamine, 1 mM sodium pyruvate, and 25 mM HEPES, under standard conditions (37°C, 5% CO2, humidified atmosphere) in tissue culture flasks (Nunc). Adherent macrophages were detached by gentle scraping and counted using Trypan blue exclusion (Sigma-Aldrich). Cells were adjusted to 1 × 105 cells/mL in complete DMEM, and 100 μL were seeded per well in 96-well plates, followed by overnight incubation. Spent medium was removed and replaced with 200 μL of yeast cell suspension, previously subcultured overnight in YPD and adjusted to 2.5 × 106 cells/mL in DMEM. The plates were then incubated for an additional 4 h at 37°C. Finally, macrophages were lysed with 10% saponin (Sigma-Aldrich), and colony-forming units (CFUs) were determined by plating on YPD agar. Control wells included macrophages alone and yeast alone. Data represent the mean of three independent biological replicates, each measured in triplicate. Imaging of parallel 20 h yeast–macrophage co-incubations, including assays using macrophages pre-activated overnight by exposure to heat-killed Candida cells, was conducted with a THUNDER Ready DMi8 inverted fluorescence microscope (Leica Microsystems).
2.15 Statistical analysis
Unless mentioned otherwise, all phenotypic assays were performed with four biological replicates, measured in triplicate. Statistical analyses were conducted using GraphPad Prism 9 (GraphPad Software). For datasets with normal distribution, one-way ANOVA followed by Tukey´s post hoc test was applied to determine significance. Survival data were analyzed using the Kaplan-Meier method and compared with the Mantel-Cox log-rank test. Statistical significance is indicated as follows: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
3 Results
3.1 CHT3 deletion in WT backgrounds affects cell separation
Given its potential as a promising vaccine candidate, this study aims to further elucidate the role of the chitinase Cht3 in C. albicans, particularly in cell surface remodeling during growth and infection. Previous studies have generated cht3Δ mutants using strains with auxotrophic markers or the Ura-blaster system (; ). As the genetic modifications in such parental strains might affect phenotypic studies, here we generated and studied mutants in - two different - WT backgrounds: reference strain SC5314 (clade 1; ) and clinical isolate 124A. The latter is a clade 16 strain isolate from an immunocompromised patient with invasive candidiasis () against which prior vaccination with a Cht3-containing DTT cell extract from SC5314 provided protection (; ).
Implementing the CRISPR-Cas9 technique during transformation enabled the generation of homozygous cht3Δ mutants through two independent strategies: either by simultaneous deletion of both alleles in a single transformation event, or by sequential deletion of the two alleles (Supplementary Table S1). In all phenotypic assays, the independent mutants showed identical phenotypic behavior.
Deleting CHT3 in both strain backgrounds had no measurable impact on their fitness at 30°C or 37°C (Supplementary Table S3). However, microscopical analysis showed a clear defect in cell separation at both temperatures in both backgrounds in the homozygous but not the heterozygous mutants (Figure 1A; Supplementary Figure S2A; data at 30°C not shown). Cell separation at 37°C was further studied quantitatively by FC following a washing step in PBS, confirming the microscopic observations (Figure 1B; Supplementary Figure S2B). Results of complementary sedimentation assays were consistent with the cell separation phenotype, and further highlighted differences between the genetic backgrounds. The 124A strain sedimented significantly faster than the SC5314 WT at the later timepoints (Figure 1C; Supplementary Figure S2C), suggesting the formation of larger or more cohesive cellular aggregates.
Figure 1
Such cellular aggregation may, in turn, influence biofilm formation, thereby potentially linking alterations in cell surface architecture to pathogenic potential. Both strains exhibit low biofilm formation in YPD medium. In contrast, reference strain SC5314 but not clinical isolate 124A forms significantly more biofilm mass in RPMI - 1640 medium (Supplementary Figure S3A), however, this was not altered by deletion of CHT3 (not shown). These results were corroborated by the biofilm metabolic activity (XTT) assay (Supplementary Figure S3B).
3.2 Cht3 activity affects the cell wall organization in surface-exposed chitin
As Cht3 plays a key role in mother-daughter cell separation, we studied the impact of CHT3 deletion on cell wall organization (Figure 2; Supplementary Figure S4). Total chitin content was first quantified biochemically. This assay revealed no significant differences between WT strains and cht3Δ mutants. Similarly, no variation in protein content was detected in the same samples (Figure 2A; Supplementary Figure S4A).
Figure 2
In addition, quantitative FC analysis was performed using CFW and WGA-FITC, which are known to bind chitin polymers and exposed N-acetylglucosamine residues, respectively (; ). During logarithmic growth, homozygous mutants showed a 24 - 25% increase in CFW binding in both genetic backgrounds. Consistent with the absence of cell separation defects, heterozygous mutants did not show increased CFW binding. In the stationary phase, when cell division is ceased, no or almost no increase in CFW binding was observed, with only a marginal increase in the homozygous mutants in strain 124A (Figure 2B; Supplementary Figure S4B). Remarkably, with respect to WGA binding during logarithmic growth, the heterozygous mutants in SC5314 already showed a marked (almost two-fold) increase, whereas in the 124A background only the homozygous mutants showed (2.5-fold) increased binding. The latter tendency was also the case during the stationary phase in both backgrounds (Figure 2C; Supplementary Figure S4C). More intense staining in confocal fluorescent microscopy images (Figures 2D, E; Supplementary Figures S4D, E) corroborates these data. Thus, rather than affecting the total cell wall chitin, these data point to differences in surface-exposed chitin molecules because of the presence or absence of Cht3 chitinase activity.
To assess alterations in cell wall homeostasis, the sensitivity of WT and cht3Δ mutants to various cell surface stressors was evaluated (Figure 2F; Supplementary Figure S4F). Drop assays showed that the clinical strain (124A) is more sensitive to CFW and CR than the reference strain (SC5314). In both genetic backgrounds, homozygous mutants exhibited increased resistance to these stresses compared to both parental and heterozygous strains. However, this effect was less pronounced in the clinical isolate under CR exposure, likely due to its inherent high sensitivity. CFW spot assay results were confirmed by microdilution assays (data not shown), which demonstrated a four-fold higher resistance in SC5314 compared to 124A. Further, homozygous deletion of CHT3 led to a four-fold increased resistance in SC5314, but not in 124A background. In contrast, spot assays with other stressors such as caffeine (a cell wall integrity pathway inhibitor), SDS (a membrane-disrupting detergent), or caspofungin (a β-1,3-glucan synthase inhibitor), did not show differences between WT and mutants in either background (data not shown). To further evaluate cell wall integrity, sensitivity to Zymolyase, a β-1,3-glucanase preparation, was tested in cells grown to logarithmic phase at 37°C (Figure 2G; Supplementary Figure S4G). The results indicated that the SC5314 strain is slightly more sensitive than the clinical strain. In both genetic backgrounds, the homozygous mutants exhibited a distinct resistance “blob”, which was more pronounced in the 124A strain. Although not clear, this resistance could be related to the separation defect observed in the homozygous mutants.
3.3 High expression of CHT3 in strain 124A but not in SC5314 leads to compensatory upregulation of CHT2
Potential compensatory transcriptional responses to CHT3 deletion were measured by qPCR of the four chitinase genes in cells grown to exponential and stationary phases (Figure 3; Supplementary Figures S5, S6). Consistent with their proposed role in cell separation during growth, CHT1, CHT2, and CHT3 showed highest expression during the logarithmic phase, while their transcript levels were much lower in stationary phase. A similar trend was observed for CHT4, a gene linked to sporulation (), although the difference between the growth phases was less pronounced. Among the four chitinase genes analyzed, CHT3 exhibited the highest expression levels, followed by CHT2. In contrast, CHT1, and to a lesser extent CHT4, were minimally expressed in both genetic backgrounds, with transcript levels barely exceeding background detection thresholds. Notably, loss of only one CHT3 allele led to a marked reduction in CHT3 expression during logarithmic growth in both SC5314 and 124A strains, indicating a strong dependence on gene dosage. Interestingly, deletion of CHT3 was accompanied by a two- to three-fold compensatory upregulation of CHT2 in both heterozygous and homozygous cht3Δ mutants in the 124A background, a response that was not observed in SC5314. There, homozygous CHT3 deletion resulted in a three-fold decrease in CHT2 expression. This strain-dependent difference was further reflected in the global expression profiles of the chitinase genes during logarithmic growth. While they generally showed higher expression in SC5314, CHT3 showed higher transcript levels in 124A. The loss of this high CHT3 expression in 124A might explain the possible compensatory upregulation of CHT2 in both the heterozygous and the homozygous mutants observed in this background. Finally, the qPCR analysis also validated the CHT3 gene deletions.
Figure 3
3.4 Deletion of CHT3 decreases in vivo virulence of C. albicans
As previously described, homozygous cht3Δ mutants from both genetic backgrounds show cell separation defects when grown in liquid media. Interestingly, this was not the case when cells were cultured on solid Winge media at 30°C (Supplementary Figure S7A), a nutrient-limited medium compared to YPD. This medium was therefore chosen to prepare yeast inocula for infection experiments.
Mice infected with either homozygous or heterozygous cht3Δ mutants in the 124A strain background exhibited better survival and welfare compared to those infected with the WT strain (Figure 4). All animals challenged with the WT strain succumbed to infection by day 14, with a median survival time of eleven days. In contrast, median survival times for mice infected with the heterozygous and homozygous mutants were 21 and 15 days, respectively (Figures 4A, B). While the difference with WT reached statistical significance for the heterozygous mutant (p = 0.0139), this was not the case for the homozygous mutant (p = 0.0810); though, also no significant differences were observed between the two different mutant strains (p = 0.4556). Welfare scores and weight loss analysis further supported these findings, with both mutant-infected groups showing better outcomes compared to WT-infected mice (Figures 4C, D). Animals infected with the homozygous mutant exhibited overall lower weight loss than those infected with the heterozygous mutant. Altogether, these results indicate that deletion of a single CHT3 allele is sufficient to reduce virulence in vivo. In conclusion, CHT3 deletion reduces mortality and improves the overall health of the infected mice in comparison to the WT strain.
Figure 4
C. albicans infections in mice often result in kidney colonization (). Given the lower virulence displayed by the mutant strains, histological analysis of the kidneys of infected animals was carried out (Figure 5). In all analyzed mice, filamentous C. albicans cells were observed, indicating that deletion of CHT3 does not impair the capacity of C. albicans to filament during the infection process, consistent with in vitro filamentation-inducing cultures in liquid Winge (Supplementary Figure S7B) and RPMI medium (not shown).
Figure 5
The in vivo virulence of cht3Δ mutants was also tested using larvae of the wax moth G. mellonella as an alternative infection model. In this more primitive host, no significant differences in virulence were observed between the WT strain and the mutants in either genetic background (data not shown).
3.5 CHT3 deletion affects C. albicans killing by macrophages
As cht3Δ mutants showed reduced virulence in vivo, we next explored whether this phenotype could be linked to altered interactions with the host immune system. To this end, the murine macrophage cell line J774A.1 was used as an in vitro model to assess fungal survival following co-incubation with immune cells. Survival was quantified by calculating CFU ratios for the WT strain 124A and the corresponding heterozygous and homozygous cht3Δ mutants (Figure 6). Comparison of CFU ratios after 4 hours of incubation with and without macrophages showed a gene dosage-dependent increase in survival for the mutant strains, indicating enhanced resistance to macrophage-mediated killing (Figure 6A). A similar trend was observed when comparing CFU ratios after 4 hours of co-incubation with macrophages relative to the initial time point (Figure 6B), suggesting better persistence or proliferation of cht3Δ mutants in the presence of immune cells. In the absence of macrophages, no significant differences in growth were observed among the Candida strains (Figure 6C), indicating that the enhanced survival phenotype is specific to the interaction with macrophages and not due to intrinsic growth differences. To follow on this, incubations with macrophages were extended to 20 h and analyzed by microscopy (Figure 6D). As observed at 4 h, all yeast strains exhibited comparable growth in the absence of macrophages. However, during co-incubation, the mutant strains showed increased cell densities compared to the WT strain, especially the homozygous mutant. Moreover, the mutants formed more abundant cellular clumps, also indicative of reduced phagocytosis or killing efficiency. Interestingly, this phenotype was mitigated when macrophages were pre-activated, leading to reduced yeast densities across all strains. These findings suggest that macrophage activation plays an important role in controlling C. albicans infection, even in strains with enhanced resistance such as the homozygous cht3Δ mutant.
Figure 6
4 Discussion
The role of chitinases in C. albicans pathogenesis is not precisely known. In earlier studies, of the four chitinases in C. albicans, CHT3 was reported to encode the predominant chitinase and crucial for proper mother-daughter separation during yeast cell division (; ), findings that are corroborated by our study. However, until now it has not been demonstrated that Cht3 is required for full virulence.
Cht3 is a secreted and cell surface protein that has been identified as a major antigen of interest present in DTT cell extracts during mouse immunization experiments. Since then, it has been employed in the development of a novel vaccine formulation against systemic C. albicans infections (, ; ). In this context, immunization with liposomal formulations containing both Cht3 and Sap2 conferred 50% protection against disseminated candidiasis in a murine model ().
Aiming to better understand the role of Cht3 in C. albicans cell wall organization and virulence, CHT3 deletion mutants were generated in two genetically distinct WT strains. The combination of RNP-based CRISPR-Cas9 and the SAT1 flipper system predominantly yielded heterozygous mutants, with a minority of homozygous deletions obtained in a single transformation event. The initially obtained heterozygous mutants were converted into homozygous through a second round of transformation, resulting in sets of independent mutants exhibiting consistent phenotypic behavior. The use of two distinct genetic backgrounds further adds robustness to our phenotypic analyses. Moreover, as the SAT1 flipper system does not employ auxotrophic markers, possible influence on virulence phenotypes by ectopic expression of marker genes is being avoided, and ´clean´ mutants are obtained after flipping out the antibiotic resistance marker.
When studying the effect of CHT3 deletion on yeast growth, homozygous but not heterozygous cht3Δ mutants exhibited clear cell separation defects. While this is consistent with earlier studies (; ) and supports the validity of our mutants, the previous studies were performed at 30°C whereas we consistently performed our studies at the clinically relevant temperature of 37°C. Despite the observed cell separation defect, the growth rate of C. albicans cells was not impaired by deleting CHT3. The same was true for the filamentation capacity, as observed by histological analysis of infected murine kidneys, in vitro culturing, and yeast-macrophage co-incubations. These findings align with previously reported results from in vitro hyphal-induction assays (). In the latter publication, expression of one CHT3 allele under control of the regulatable MAL2-promoter resulted in the reversion of the cell separation defect when cells were grown in the presence of maltose (), confirming the Cht3 dependence of the phenotype. Because of the consistency of the observed phenotypes with the earlier studies, which used different genetic backgrounds and different knockout strategies, we did not further validate our data by incorporating a reconstituted strain. This should be noted as it is considered a relevant point, especially in virulence studies.
Regarding cell wall composition, biochemical determination indicated no differences in total chitin content between WT and mutant strains. However, CFW- and WGA-binding experiments suggested a marked increase in surface-exposed chitin in the mutants. Additionally, CHT3 deletion led to increased resistance to CFW, CR, and Zymolyase. For CFW, this seems to contradict the somewhat increased sensitivity observed with Ura-blaster mutants (). However, this discrepancy may be attributed to differences in experimental conditions, as the earlier study was conducted at 30°C, whereas our assays were performed at 37°C.
These sensitivity assays also marked architectural differences in the cell walls of the two WT strains used in this study, with SC5314 being more resistant to the cell wall perturbants CFW and CR, but more sensitive to β-1,3-glucan hydrolyzing enzyme preparation Zymolyase. Such differences between the two WT strains, and their different responses to CHT3 deletion, for instance, in compensatory CHT2 expression (see below), emphasize the importance of being cautious when extrapolating findings obtained with one genetic background to others.
Significant differences between the two genetic backgrounds used in our study also became apparent when analyzing CHT gene expression, in particular, regarding CHT2 and CHT3. The level of CHT3 expression was approximately two-fold higher in strain 124A than in SC5314. In the clinical isolate background, the loss of this high level of CHT3 transcription appeared to trigger a compensatory two- to three-fold upregulation of CHT2 in homozygous as well as heterozygous mutants. This compensatory response was absent in the SC5314 background, where the homozygous mutants in fact showed decreased CHT2 transcript levels. qPCR analysis also demonstrated that, to sustain mother-daughter cell separation, yeast cells undergoing active cell division showed much higher CHT transcript levels compared to cells grown to stationary phase. Furthermore, our results corroborate previous findings that CHT2 and CHT3 are the main chitinase-encoding genes in C. albicans (; ; ).
Analysis of mouse survival as well as their welfare scores and weight, revealed that CHT3 deletion led to attenuated virulence. This reduction might be related to the cell separation defect observed in homozygous cht3Δ mutants, as impaired separation might hamper effective dissemination. Therefore, it was somewhat surprising that heterozygous cht3Δ mutants, which did not show detected cell separation defects, already exhibited attenuated virulence, and that this phenotype was not exacerbated in homozygous mutants. It is important to stress that CHT3 expression in the heterozygous mutant was reduced by more than 90%, which seems to explain, at least in part, the lack of sufficient chitinase activity to sustain full virulence. Chitinases have also been linked to pathogenesis in mammalian infections caused by Paracoccidioides brasiliensis and in bacterial pathogens, such as Vibrio cholerae, Serratia marcescens, Legionella pneumophila, and Listeria monocytogenes (; ; ; ).
Interestingly, in experiments where yeast cells were co-incubated for 4 h with non-activated murine macrophages, cht3Δ mutants showed higher survival than the parental strain. However, macrophage pre-activation significantly enhanced antifungal activity, reducing fungal burden across all CHT3 genotypes. These findings highlight the critical role of the adaptive immune system in orchestrating effective antifungal defenses by activating innate immune cells, particularly macrophages. The enhanced survival of cht3Δ mutants only in the presence of non-activated macrophages may stem from impaired immune activity, potentially due to cell separation defects and larger fungal structures, as well as an increased level of surface-exposed chitin, which may interfere with efficient recognition by the immune system (; ). The reduced virulence of cht3Δ mutants in mice emphasizes the importance of adaptive immunity in priming effective innate responses. The lack of virulence differences in G. mellonella may reflect the limitations of this model for studying fungal virulence as this organism possesses a more rudimentary immune system lacking adaptive components. This seems particularly relevant for phenotypes where complex interactions between innate and adaptive immunity are critical to host–pathogen dynamics.
Previous studies have demonstrated that chito-oligomers can induce various types of macrophage activation, depending in part on their size (; ; ). Chito-oligomers with a minimum of six GlcNAc residues can be phagocytosed and activate TLR2 on macrophages, leading to M1 polarization characterized by significant TNF-α production. Smaller oligomers interact with other pattern recognition receptors and induce M2 macrophages, which produce anti-inflammatory cytokines, such as IL-10. When this occurs during the early stages of fungal infection, it suppresses the Th1/Th17 protective immune response (). Paracoccin, a protein with chitinase activity from P. brasiliensis, was found to enhance the severity of infections in mice and to hydrolyze cell wall chitin into smaller chito-oligomers. Once released, these chito-oligomers can exert a regulatory role on cytokine production by neighboring macrophages and thus influence the host’s defense mechanisms ().
Cht3 can release various chito-oligomers from the chitin/chito-oligomer substrates tested, with larger products being initially produced and these then being broken down to chitobiose as the principal end product, but with chitotriose and the monomer GlcNAc being also observed (). Therefore, the severity of the systemic infection in mice infected with the WT in comparison with the mutants could be partly attributed to a possible immunomodulation by the chito-oligomers produced. However, the exact mechanism responsible for the decrease in virulence in the C. albicans cht3Δ mutants remains to be determined.
It is important to note that, while mammals do not synthesize chitin, the presence of mammalian chitinases has been linked to host inflammatory responses against fungi. However, their expression in inflammatory responses in the apparent absence of microbial infection, as seen in diseases like asthma, has made their role puzzling (; ). There are two known human chitinases with chitinolytic activity, chitotriosidase and acidic mammalian chitinase (). The specific targets of these chitinases have not been identified yet, but they might encompass endogenous carbohydrates like heparan sulfate and hyaluronic acid, which share structural similarities with chitin (), or exogenous carbohydrates such as fungal chitin (), contributing to the presence of chito-oligomers in the medium. Thus, the roles of chitinases in host-fungus interaction, particularly during C. albicans infections, is a very relevant topic and still much remains to be unveiled.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.
Ethics statement
The animal study was approved by Animals used for Experimental and other Scientific Purposes (ETS 123), the 2010/63/EU directive, and Portuguese rules (DL 113/2013). Procedures were approved by the i3S institutional board responsible for animal welfare (ORBEA) and authorization to perform the experiments was issued by the competent national authority (Direção Geral de Alimentação e Veterinária) with the reference number 014036/2019-07-24.i3S. The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
MB-M: Visualization, Methodology, Data curation, Investigation, Writing – review & editing, Validation, Formal Analysis, Writing – original draft. AC-B: Formal Analysis, Visualization, Writing – original draft, Validation, Methodology, Data curation, Investigation. MA: Methodology, Writing – original draft, Investigation. AM: Investigation, Methodology, Writing – review & editing. SB: Investigation, Methodology, Writing – original draft. MV: Data curation, Funding acquisition, Resources, Validation, Writing – review & editing. SF-S: Investigation, Methodology, Writing – original draft. AC: Investigation, Methodology, Formal Analysis, Resources, Validation, Writing – review & editing. PG: Resources, Writing – review & editing, Investigation, Formal Analysis, Validation, Methodology, Conceptualization, Data curation, Funding acquisition, Supervision, Visualization, Writing – original draft. PS: Writing – original draft, Resources, Writing – review & editing, Investigation, Funding acquisition, Data curation, Formal Analysis, Visualization, Methodology, Conceptualization, Supervision, Validation, Project administration.
Funding
The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by the Portuguese Foundation for Science and Technology (FCT) in the framework of the Strategic Funding UIDP/04050/2020, LA/P/0069/2020 and COMPETE2030-FEDER_00708500. FCT is also acknowledged for the Ph.D. scholarships SFRH/BD/133513/2017 and COVID/BD/152169/2021 (ACB) and 2022.11315.BD (AM). This work was also supported by grants (PID2020-117983RB-I00, CNS2022-135375, and JDC2023-051226-I) from the Spanish Government MCIN/AEI/10.13039/501100011033, grants (SBPLY/19/180501/000114 and SBPLY/23/180225/000029) from the Regional Government of Castilla-La Mancha, and grant 2023-GRIN-34150 from UCLM, all co-funded by the European Regional Development Fund (ERDF), a way of making Europe.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Generative AI statement
The author(s) declare that Generative AI was used in the creation of this manuscript. AI was used to correct English grammar and improve text readability.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2025.1654710/full#supplementary-material
References
1
AlvaradoM.Gómez-NavajasJ. A.Blázquez-MuñozM. T.Gómez-MoleroE.Fernández-SánchezS.ErasoE.et al. (2024). The good, the bad, and the hazardous: comparative genomic analysis unveils cell wall features in the pathogen Candidozyma auris typical for both baker’s yeast and Candida. FEMS Yeast Res.24, foae039. doi: 10.1093/femsyr/foae039
2
CarneiroC.CorreiaA.CollinsT.VilanovaM.PaisC.GomesA. C.et al. (2015). DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system. Eur. J. Pharm. Biopharm.89, 190–200. doi: 10.1016/j.ejpb.2014.11.028
3
CarneiroC.CorreiaA.LimaT.VilanovaM.PaisC.GomesA. C.et al. (2016). Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis. Acta Biomater.39, 133–145. doi: 10.1016/j.actbio.2016.05.001
4
ChaffinW. L.López-RibotJ. L.CasanovaM.GozalboD.MartinezJ. P. (1998). Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev.62, 130–180. doi: 10.1128/MMBR.62.1.130-180.1998
5
ChaudhuriS.BrunoJ. C.AlonzoF.3rdXayarathB.CianciottoN. P.FreitagN. E. (2010). Contribution of chitinases to Listeria monocytogenes pathogenesis. Appl. Environ. Microbiol.76, 7302–7305. doi: 10.1128/AEM.01338-10
6
CorreiaA.LermannU.TeixeiraL.CercaF.BotelhoS.da CostaR. M.et al. (2010). Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect. Immun.78, 4839–4849. doi: 10.1128/IAI.00248-10
7
Costa-BarbosaA.FerreiraD.PachecoM. I.CasalM.DuarteH. O.GomesC.et al. (2024). Candida albicans chitinase 3 with potential as a vaccine antigen: production, purification, and characterisation. Biotechnol. J.19, e2300219. doi: 10.1002/biot.202300219
8
Costa-BarbosaA.PachecoM. I.CarneiroC.BotelhoC.GomesA. C.Real OliveiraM. E. C. D.et al. (2023). Design of a lipid nano-delivery system containing recombinant Candida albicans chitinase 3 as a potential vaccine against fungal infections. BioMed. Pharmacother.166, 115362. doi: 10.1016/j.biopha.2023.115362
9
Costa-BarbosaA.PachecoM. I.GomesA. C.CollinsT.VilanovaM.PaisC.et al. (2025). Pre-clinical evaluation of a divalent liposomal vaccine to control invasive candidiasis. NPJ Vaccines10, 124. doi: 10.1038/s41541-025-01183-0
10
CostaT. A.BazanS. B.FeriottiC.AraujoE. F.BassiE.LouresF. V.et al. (2013). In pulmonary paracoccidioidomycosis IL-10 deficiency leads to increased immunity and regressive infection without enhancing tissue pathology. PloS Negl. Trop. Dis.7, e2512. doi: 10.1371/journal.pntd.0002512
11
CôteP.HoguesH.WhitewayM. (2009). Transcriptional analysis of the Candida albicans cell cycle. Mol. Biol. Cell.20, 3363–3373. doi: 10.1091/mbc.e09-03-0210
12
Da SilvaC. A.ChalouniC.WilliamsA.HartlD.LeeC. G.EliasJ. A. (2009). Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. J. Immunol.182, 3573–3582. doi: 10.4049/jimmunol.0802113
13
DebRoyS.DaoJ.SoderbergM.RossierO.CianciottoN. P. (2006). Legionella pneumophila type II secretome reveals unique exoproteins and a chitinase that promotes bacterial persistence in the lung. Proc. Natl. Acad. Sci. U S A.103, 19146–19151. doi: 10.1073/pnas.0608279103
14
De GrootP. W. J.De BoerA. D.CunninghamJ.DekkerH. L.De JongL.HellingwerfK. J.et al. (2004). Proteomic analysis of Candida albicans cell walls reveals covalently bound carbohydrate-active enzymes and adhesins. Eukaryot Cell.3, 955–965. doi: 10.1128/EC.3.4.955-965.2004
15
De GrootP. W. J.HellingwerfK. J.KlisF. M. (2003). Genome-wide identification of fungal GPI proteins. Yeast.20, 781–796. doi: 10.1002/yea.1007
16
DünklerA.JordeS.WendlandJ. (2008). An Ashbya gossypii cts2 mutant deficient in a sporulation-specific chitinase can be complemented by Candida albicans CHT4. Microbiol. Res.163, 701–710. doi: 10.1016/j.micres.2008.08.005
17
DünklerA.WaltherA.SpechtC. A.WendlandJ. (2005). Candida albicans CHT3 encodes the functional homolog of the Cts1 chitinase of Saccharomyces cerevisiae. Fungal Genet. Biol.42, 935–947. doi: 10.1016/j.fgb.2005.08.001
18
FuchsK.Cardona GloriaY.WolzO. O.HersterF.SharmaL.DillenC. A.et al. (2018). The fungal ligand chitin directly binds TLR2 and triggers inflammation dependent on oligomer size. EMBO Rep.19, e46065. doi: 10.15252/embr.201846065
19
GrahlN.DemersE. G.CrockerA. W.HoganD. A. (2017). Use of RNA-protein complexes for genome editing in non-albicans Candida species. mSphere.2, e00218–e00217. doi: 10.1128/mSphere.00218-17
20
GuineaJ.MeletiadisJ.Arikan-AkdagliS.GiskeC.MuehlethalerK.ArendrupM. C. (2023). “EUCAST Definitive Document E.Def 7.4. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts,” in EUCAST antifungal MIC method for yeasts. Available online at: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Files/EUCAST_E.Def_7.4_Yeast_definitive_revised_2023.pdf (Accessed January 9, 2025).
21
IranzoM.AguadoC.PallottiC.CanizaresJ. V.MormeneoS. (2002). The use of trypsin to solubilize wall proteins from Candida albicans led to the identification of chitinase 2 as an enzyme covalently linked to the yeast wall structure. Res. Microbiol.153, 227–232. doi: 10.1016/S0923-2508(02)01307-4
22
JawaleC. V.BiswasP. S. (2021). Local antifungal immunity in the kidney in disseminated candidiasis. Curr. Opin. Microbiol.62, 1–7. doi: 10.1016/j.mib.2021.04.005
23
KapteynJ. C.Ter RietB.VinkE.BladS.De NobelH.Van Den EndeH.et al. (2001). Low external pH induces HOG1-dependent changes in the organization of the Saccharomyces cerevisiae cell wall. Mol. Microbiol.39, 469–479. doi: 10.1046/j.1365-2958.2001.02242.x
24
KawadaM.ChenC. C.ArihiroA.NagataniK.WatanabeT.MizoguchiE. (2008). Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein. Lab. Invest.88, 883–895. doi: 10.1038/labinvest.2008.47
25
KawadaM.HachiyaY.ArihiroA.MizoguchiE. (2007). Role of mammalian chitinases in inflammatory conditions. Keio J. Med.56, 21–27. doi: 10.2302/kjm.56.21
26
KlisF. M.BrulS. (2015). Adaptations of the secretome of Candida albicans in response to host-related environmental conditions. Eukaryot Cell.14, 1165–1172. doi: 10.1128/EC.00142-15
27
LeeC. G.Da SilvaC. A.Dela CruzC. S.AhangariF.MaB.KangM. J.et al. (2011). Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu. Rev. Physiol.73, 479–501. doi: 10.1146/annurev-physiol-012110-142250
28
McCreathK. J.SpechtC. A.RobbinsP. W. (1995). Molecular cloning and characterization of chitinase genes from Candida albicans. Proc. Natl. Acad. Sci. U.S.A.92, 2544–2548. doi: 10.1073/pnas.92.7.2544
29
Mora-MontesH. M.NeteaM. G.FerwerdaG.LenardonM. D.BrownG. D.MistryA. R.et al. (2011). Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect. Immun.79, 1961–1970. doi: 10.1128/IAI.01282-10
30
MulhernS. M.LogueM. E.ButlerG. (2006). Candida albicans transcription factor Ace2 regulates metabolism and is required for filamentation in hypoxic conditions. Eukaryot Cell.5, 2001–2013. doi: 10.1128/EC.00155-06
31
OberC.ChuppG. L. (2009). The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases. Curr. Opin. Allergy Clin. Immunol.9, 401–408. doi: 10.1097/ACI.0b013e3283306533
32
OddsF. C.BrownA. J.GowN. A. (2004). Candida albicans genome sequence: a platform for genomics in the absence of genetics. Genome Biol.5, 230. doi: 10.1186/gb-2004-5-7-230
33
PierceC. G.UppuluriP.TummalaS.Lopez-RibotJ. L. (2010). A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms. J. Vis. Exp. (44), e2287. doi: 10.3791/2287
34
PitanguiN. S.FernandesF. F.GonçalesR. A.Roque-BarreiraM. C. (2021). Virulence vs. immunomodulation: roles of the paracoccin chitinase and carbohydrate-binding sites in Paracoccidioides brasiliensis infection. Front. Mol. Biosci.8, 700797. doi: 10.3389/fmolb.2021.700797
35
ReithoferV.Fernandez-PereiraJ.AlvaradoM.de GrootP.EssenL. O. (2021). A novel class of Candida glabrata cell wall protein with β-helix fold mediates adhesion in clinical isolates. PloS Pathog.17, e1009980. doi: 10.1371/journal.ppat.1009980
36
ReußO.VikÅ.KolterR.MorschhäuserJ. (2004). The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene.341, 119–127. doi: 10.1016/j.gene.2004.06.021
37
SampaioP.SantosM.CorreiaA.AmaralF. E.Chavez-GalarzaJ.Costa-de-OliveiraS.et al. (2010). Virulence attenuation of Candida albicans genetic variants isolated from a patient with a recurrent bloodstream infection. PloS One5, e10155. doi: 10.1371/journal.pone.0010155
38
SelvagginiS.MunroC. A.PaschoudS.SanglardD.GowN. A. R. (2004). Independent regulation of chitin synthase and chitinase activity in Candida albicans and Saccharomyces cerevisiae. Microbiology (Reading)150, 921–928. doi: 10.1099/mic.0.26661-0
39
SherringtonS. L.SorsbyE.MahteyN.KumwendaP.LenardonM. D.BrownI.et al. (2017). Adaptation of Candida albicans to environmental pH induces cell wall remodeling and enhances innate immune recognition. PloS Pathog.13, e1006403. doi: 10.1371/journal.ppat.1006403
40
SorgoA. G.HeilmannC. J.DekkerH. L.BrulS.De KosterC. G.KlisF. M. (2010). Mass spectrometric analysis of the secretome of Candida albicans. Yeast27, 661–672. doi: 10.1002/yea.1775
41
VegaK.KalkumM. (2012). Chitin, chitinase responses, and invasive fungal infections. Int. J. Microbiol.2012, 920459. doi: 10.1155/2012/920459
42
WagenerJ.MalireddiR. K.LenardonM. D.KoberleM.VautierS.MacCallumD. M.et al. (2014). Fungal chitin dampens inflammation through IL - 10 induction mediated by NOD2 and TLR9 activation. PloS Pathog.10, e1004050. doi: 10.1371/journal.ppat.1004050
Summary
Keywords
Candida albicans, candidiasis, chitinase, host-pathogen interactions, cell separation, cell wall
Citation
Blázquez-Muñoz MT, Costa-Barbosa A, Alvarado M, Mendonça A, Benkhellat S, Vilanova M, Fernández-Sánchez S, Correia A, de Groot PWJ and Sampaio P (2025) Loss of CHT3 in Candida albicans wild-type strains increases surface-exposed chitin and affects host-pathogen interaction. Front. Cell. Infect. Microbiol. 15:1654710. doi: 10.3389/fcimb.2025.1654710
Received
26 June 2025
Accepted
18 August 2025
Published
05 September 2025
Volume
15 - 2025
Edited by
Nicolas Papon, Université d’Angers, France
Reviewed by
Ian A. Cleary, Grand Valley State University, United States
Prashant R. Desai, University of Wisconsin-Madison, United States
Updates
Copyright
© 2025 Blázquez-Muñoz, Costa-Barbosa, Alvarado, Mendonça, Benkhellat, Vilanova, Fernández-Sánchez, Correia, de Groot and Sampaio.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Paula Sampaio, psampaio@bio.uminho.pt
†These authors have contributed equally to this work and share first authorship
‡These authors have contributed equally to this work and share last authorship
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.